See every side of every news story

Published 10 days ago • loading... • Updated 10 days ago

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells $400,603.24 in Stock

Summary by tickerreport.com

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) Director John Gordon Freund sold 11,659 shares of the business’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $34.36, for a total value of $400,603.24. Following the sale, the director directly owned 23,129 shares in the […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

tickerreport.com

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells $400,603.24 in Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) Director John Gordon Freund sold 11,659 shares of the business’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $34.36, for a total value of $400,603.24. Following the sale, the director directly owned 23,129 shares in the […]

10 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated10 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

tickerreport.com broke the news in 10 days ago on Wednesday, August 13, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics